EGFR and head and neck squamous cell carcinoma: EGFR is frequently reported to be overexpressed in HNSCC, and such overexpression correlates with poor prognosis: almost 80% of HNSCC studies demonstrate decreased OS and DFS for patients with cancers overexpressing EGFR (27).